Teva Pharmaceutical Industries reported $12.68B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Aspen Pharmacare ZAR 9.5B 19.84B Jun/2026
Cipla INR 4.69B 874.1M Sep/2026
Dr.Reddys Laboratories INR 11.92B 284M Sep/2026
Guangzhou Baiy CNY 6.23B 736.83M Sep/2026
Jiangsu Hengrui CNY 29.02M 9.21M Sep/2026
Kalbe Farma IDR 173.39B 18.22B Sep/2026
Richter Gedeon HUF 79.37B 64.3B Jun/2026
Sh Fosun Pharma CNY 18.53B 2.22B Sep/2026
Sun Pharmaceuticals INR 4.17B 237.8M Sep/2026
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026